Acenxion Biosystems is a privately funded company developing automated medical diagnostic systems for precision medicine.
Acenxion Biosystems has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Acenxion Biosystems's investors include National Institute of Allergy and Infectious Diseases, Centennial Investors.
Acenxion Biosystems is headquartered in Lawrence, United States.
Acenxion Biosystems is a privately funded company developing automated medical diagnostic systems for precision medicine.
Acenxion Biosystems is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Acenxion Biosystems — Funding & Investors." VCBacked, August 14, 2024, https://www.vcbacked.co/company/acenxion-biosystems. Accessed September 30, 2026.
VCBacked. (2024). Acenxion Biosystems — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/acenxion-biosystems
{{cite web |title=Acenxion Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/acenxion-biosystems |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated